Trade Mark Journal No.2026/013 27 March 2026

UK00004353713 12 March 2026 (5)

KIZLEVY

Class 5: Pharmaceutical preparations and substances for the treatment of dermatological, musculoskeletal, rheumatological, gastroenterological, inflammatory, and immune system related diseases and disorders.

AbbVie Inc.

Representative: Carpmaels & Ransford LLP